Jun'05 | Jun'06 | Jun'07 | Jun'08 | Jun'09 | Jun'10 | Jun'11 | Jun'12 | Jun'13 | Jun'14 | Jun'15 | Jun'16 | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $0.5 | $0.6 | $0.4 | $0.7 | $1.0 | $1.3 | $1.5 | $1.8 | $2.2 | $2.4 | $2.5 | $2.5 | $2.4 | $2.2 | $2.8 | $4.3 | $3.3 | $5.3 | $6.1 | $6.9 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, ResMed Inc.'s last 12-month EPS is $4.0, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, ResMed Inc.'s EPS growth was (33.4%). The average annual EPS growth rates for ResMed Inc. have been 7.2% over the past three years, 4.9% over the past five years.
Over the last year, ResMed Inc.'s EPS growth was (33.4%), which is lower than industry growth of 3.3%. It indicates that ResMed Inc.'s EPS growth is Bad.